Open AccessFailure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Author(s) -
Ingo Kleiter
Publication year - 2012
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneurol.2011.216
Subject(s) - natalizumab , neuromyelitis optica , medicine , multiple sclerosis , neurology , expanded disability status scale , pediatrics , surgery , immunology , psychiatry
To describe first experiences with the integrin inhibitor natalizumab, given to patients with suspected relapsing-remitting multiple sclerosis (MS) who were later diagnosed with aquaporin 4-positive neuromyelitis optica (NMO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom